Article

PDF: Update on Drugs & Devices: May-June 2022

Name: PDF: Update on Drugs & Devices: May-June 2022
Price: 1.99 USD
Availability: InStock

$1.99

PDF Download: This update covers Nivolumab + Relatlimab-rmbw for IV use – Opdualag™ (Bristol-Myers Squibb), Sirolimus topical gel 0.2% – Hyftor™ (Nobelpharma America), Oral epinephrine – AQST-109 (Aquestive Therapeutics), and Bimekizumab for SC use – Bimzelx® (UCB Canada Inc.).

Category: Dermatology

PDF: Update on Drugs & Devices: May-June 2022

Related products

PDF: Hydrogen Peroxide Topical Solution, 40% for the Treatment of Seborrheic Keratoses

PDF: Update on Drugs & Devices: September – October 2019

PDF: Non-Invasive Gene Expression Testing to Rule Out Melanoma

PDF: Real-World Efficacy of Azelaic Acid 15% Gel for the Reduction of Inflammatory Lesions of Rosacea